Investment Thesis
Talphera is a pre-revenue pharmaceutical company burning approximately $3.4M annually with only ~13 months of cash runway at current burn rates. While the balance sheet maintains moderate leverage (0.31x debt-to-equity) and strong liquidity ratios, the absence of revenue generation, deteriorating year-over-year EPS trends (-122.6%), and lack of capital expenditure create substantial execution risk requiring near-term clinical or commercial milestones.
Strengths
- Strong liquidity position with current ratio of 5.30x and quick ratio of 5.01x
- Moderate debt-to-equity ratio of 0.31x provides financial flexibility
- Reasonable stockholders' equity base of $18.5M relative to asset size
Risks
- Zero revenue with no clear path to near-term commercialization
- Negative operating cash flow of -$3.4M annually creating urgent refinancing need
- Limited cash runway of approximately 13 months at current burn rate
- Deteriorating profitability with -122.6% year-over-year EPS decline
- Absence of capital expenditure suggests limited product development investment for pharma sector
Key Metrics to Watch
- Cash balance and runway duration relative to quarterly burn rates
- Clinical trial progression and regulatory milestones
- Revenue recognition from any commercial or partnership activities
Financial Metrics
Revenue
0.0
Net Income
-2.6M
EPS (Diluted)
$-0.10
Free Cash Flow
-3.4M
Total Assets
30.2M
Cash
3.8M
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
-13.8%
ROA
-8.5%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
5.30x
Quick Ratio
5.01x
Debt/Equity
0.31x
Debt/Assets
38.7%
Interest Coverage
N/A
Long-term Debt
5.8M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-15T10:15:39.742859 |
Data as of: 2026-03-31 |
Powered by Claude AI